Showing results (1-10 of 8,254) with videos related to

Sort By:
Pageof 826
Metabolism: Clinical and Experimental|June 1, 1976
Pathophysiologic and pharmacologic alterations in the release and action of ADHA M Moses, M Miller, D H Streeten
The Journal of Clinical Investigation|March 1, 1973
Clofibrate-induced antidiuresisA M Moses, J Howanitz, M van Gemert, et al.
The American Journal of Physiology|May 1, 1975
Polyuria and imparied ADH release following medial preoptic lesioning in the ratM van Gemert, M Miller, R J Carey, et al.
The Journal of Clinical Endocrinology and Metabolism|October 1, 1982
Altered osmotic threshold for vasopressin release and impaired thirst sensation: additional abnormalities in Kallmann's syndromeZ Hochberg, A M Moses, M Miller, et al.
The American Journal of Physiology|April 1, 1989
Osmotic thresholds for AVP release with the use of plasma and urine AVP and free water clearanceA M Moses
The Journal of Pharmacology and Experimental Therapeutics|September 1, 1975
Effect of chlorpropamide on renal response to parathyroid hormone in normal subjects and in patients with hypoparathyroidism and pseudohypoparathyroidismR Coulson, A M Moses
Endocrinology|March 1, 1980
Augmentation by chlorpropamide of 1-deamino-8-D-arginine vasopressin-induced antidiuresis and stimulation of renal medullary adenylate cyclase and accumulation of adenosine 3',5'-monophosphateA M Moses, R Coulson
The American Journal of Physiology|August 1, 1986
Urinary and metabolic clearances of arginine vasopressin in normal subjectsA M Moses, E Steciak
The American Journal of Physiology|December 1, 1993
Impairment of osmotically stimulated AVP release in patients with primary polydipsiaA M Moses, B Clayton
Endocrinology|February 1, 1985
Inhibition of hormonal activation of hepatic phosphorylase by chlorpropamide: evidence for an intracellular site of drug actionS A Blumenthal, A M Moses
Pageof 826